US 8865748
Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
granted A61KA61K31/4418A61P
Quick answer
US patent 8865748 (Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer) held by Akebia Therapeutics, Inc. expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Akebia Therapeutics, Inc.
- Grant date
- Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4418, A61P, A61P1/00, A61P1/02